SCYNEXIS, Inc. Share Price
SCYXSCYNEXIS, Inc. Stock Performance
Open $0.71 | Prev. Close $0.77 | Circuit Range N/A |
Day Range $0.71 - $0.77 | Year Range $0.57 - $1.30 | Volume 597 |
Average Traded $0.74 |
SCYNEXIS, Inc. Share Price Chart
About SCYNEXIS, Inc.
SCYNEXIS, Inc., a biotechnology company, develops medicines to overcome and prevent difficult-to-treat and drug-resistant infections in the United States. It offers BREXAFEMME for the treatment of patients with vulvovaginal candidiasis (VVC) and recurrent VVC. The company's lead product candidate is Ibrexafungerp, a drug for the treatment of invasive candidiasis and/or candidemia, refractory invasive fungal infections, invasive aspergillosis, VVC, and recurrent VVC. It also develops SCY-247 to treat systemic fungal diseases. The company has licensing and collaboration agreements with GlaxoSmithKline Intellectual Property (No. 3) Limited, Merck Sharp & Dohme Corp., Hansoh (Shanghai) Health Technology Co., Ltd., Jiangsu Hansoh Pharmaceutical Group Company Limited, CJSC (R-Pharm), and Cypralis Limited for the development, manufacture, and commercialization of ibrexafungerp. SCYNEXIS, Inc. was formerly known as SCYNEXIS Chemistry & Automation, Inc. and changed its name to SCYNEXIS, Inc. in June 2002. The company was incorporated in 1999 and is headquartered in Jersey City, New Jersey.
SCYNEXIS, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
06-Feb-26 | $0.71 | $0.77 | +10.90% |
05-Feb-26 | $0.76 | $0.70 | -8.41% |
04-Feb-26 | $0.78 | $0.76 | -0.13% |
03-Feb-26 | $0.75 | $0.76 | +1.46% |
02-Feb-26 | $0.70 | $0.75 | +5.63% |
30-Jan-26 | $0.71 | $0.71 | -4.56% |
29-Jan-26 | $0.73 | $0.74 | -4.49% |
FAQs on SCYNEXIS, Inc. Share Price
Can I buy SCYNEXIS, Inc. shares in India?
What is the share price of SCYNEXIS, Inc.?
What is the 5 year returns of SCYNEXIS, Inc.?
What are the high & low stock price of SCYNEXIS, Inc. today?
What is the 52-week high and low of SCYNEXIS, Inc. stock?